These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26111021)

  • 41. Anticonvulsant therapy for status epilepticus.
    Prasad K; Al-Roomi K; Krishnan PR; Sequeira R
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003723. PubMed ID: 16235337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stiripentol for focal refractory epilepsy.
    Brigo F; Storti M; Igwe SC
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009887. PubMed ID: 26488459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children.
    Appleton R; Macleod S; Martland T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001905. PubMed ID: 18646081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiepileptic drugs for the treatment of severe myoclonic epilepsy in infancy.
    Brigo F; Storti M
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010483. PubMed ID: 24254932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The anesthetic drug treatment of refractory and super-refractory status epilepticus around the world: Results from a global audit.
    Ferlisi M; Hocker S; Trinka E; Shorvon S;
    Epilepsy Behav; 2019 Dec; 101(Pt B):106449. PubMed ID: 31420291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of Refractory Status Epilepticus: An International Cohort Study (MORSE CODe) Analysis of Patients Managed in the ICU.
    Chiu WT; Campozano V; Schiefecker A; Rodriguez DR; Ferreira D; Headlee A; Zeidan S; Grinea A; Huang YH; Doyle K; Shen Q; Gómez D; Hocker SE; Rohaut B; Sonneville R; Hong CT; Demeret S; Kurtz P; Maldonado N; Helbok R; Fernandez T; Claassen J
    Neurology; 2022 Sep; 99(11):e1191-e1201. PubMed ID: 35918156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Provider Experience With the Use of Ketamine for Refractory Status Epilepticus.
    Tantillo G; Davis N; Granstein J; Yoo JY; Agarwal P; Reilly K; Reynolds A; Kayal G; Liang J; Jetté N
    Clin Neuropharmacol; 2024 Mar-Apr 01; 47(2):37-43. PubMed ID: 38478363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.
    Vossler DG; Bainbridge JL; Boggs JG; Novotny EJ; Loddenkemper T; Faught E; Amengual-Gual M; Fischer SN; Gloss DS; Olson DM; Towne AR; Naritoku D; Welty TE
    Epilepsy Curr; 2020 Sep; 20(5):245-264. PubMed ID: 32822230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized trial for the treatment of refractory status epilepticus.
    Rossetti AO; Milligan TA; Vulliémoz S; Michaelides C; Bertschi M; Lee JW
    Neurocrit Care; 2011 Feb; 14(1):4-10. PubMed ID: 20878265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Unease When Using Anesthetics for Treatment-Refractory Status Epilepticus: Still Far Too Many Questions.
    Opić P; Sutter R
    J Clin Neurophysiol; 2020 Sep; 37(5):399-405. PubMed ID: 32890061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transient bradycardia induced by thiopentone sodium: a unique challenge in the management of refractory status epilepticus.
    Sharma S; Nair PP; Murgai A; Selvaraj RJ
    BMJ Case Rep; 2013 Oct; 2013():. PubMed ID: 24130206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ketamine in the treatment of refractory and super-refractory status epilepticus: Experience from two centres.
    García-Ruiz M; Rodríguez PM; Palliotti L; Lastras C; Romeral-Jiménez M; Morales IG; Rey CP; Rodrigo-Gisbert M; Campos-Fernández D; Santamarina E; Carbonell BP
    Seizure; 2024 Apr; 117():13-19. PubMed ID: 38301485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review.
    Willems LM; Bauer S; Jahnke K; Voss M; Rosenow F; Strzelczyk A
    CNS Drugs; 2020 Aug; 34(8):801-826. PubMed ID: 32705422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors associated with treatment delays in pediatric refractory convulsive status epilepticus.
    Sánchez Fernández I; Gaínza-Lein M; Abend NS; Anderson AE; Arya R; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Helseth AR; Jackson MC; Kapur K; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello JJ; Tasker RC; Tchapyjnikov D; Topjian AA; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2018 May; 90(19):e1692-e1701. PubMed ID: 29643084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care.
    Prisco L; Ganau M; Aurangzeb S; Moswela O; Hallett C; Raby S; Fitzgibbon K; Kearns C; Sen A
    Seizure; 2020 Feb; 75():153-164. PubMed ID: 31623937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [S2k guidelines: status epilepticus in adulthood : Guidelines of the German Society for Neurology].
    Rosenow F; Weber J; ;
    Nervenarzt; 2021 Oct; 92(10):1002-1030. PubMed ID: 33751150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Comparative Study of Midazolam and Target-Controlled Propofol Infusion in the Treatment of Refractory Status Epilepticus.
    Masapu D; Gopala Krishna KN; Sanjib S; Chakrabarti D; Mundlamuri RC; Manohar N; Mariamma P; Satishchandra P; Umamaheswara Rao GS
    Indian J Crit Care Med; 2018 Jun; 22(6):441-448. PubMed ID: 29962746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of new versus traditional antiepileptic drugs on course and outcome of status epilepticus.
    Reindl C; Sprügel MI; Sembill JA; Mueller TM; Hagen M; Gerner ST; Kuramatsu JB; Hamer HM; Huttner HB; Madžar D
    Seizure; 2020 Jan; 74():20-25. PubMed ID: 31790940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrographic predictors of successful weaning from anaesthetics in refractory status epilepticus.
    Rubin DB; Angelini B; Shoukat M; Chu CJ; Zafar SF; Westover MB; Cash SS; Rosenthal ES
    Brain; 2020 Apr; 143(4):1143-1157. PubMed ID: 32268366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Propofol infusion syndrome in refractory status epilepticus.
    Hwang WS; Gwak HM; Seo DW
    J Epilepsy Res; 2013 Jun; 3(1):21-7. PubMed ID: 24649467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.